SLRX - Salarius Pharmaceuticals Inc

https://www.salariuspharma.com

Recent News

What's Going On With Salarius Pharmaceuticals Shares Today? - Salarius Pharmaceuticals ( NASDAQ:SLRX )

Benzinga • 2 months, 4 weeks ago • score: 0.31

Salarius Pharmaceuticals received a conditional extension from Nasdaq to regain compliance with listing rules. Shares jumped over 50% after the extension news, as it gives the company a limited window to avoid delisting. Last Chance: See the "Power Pattern" That Delivered Winners 9 Out of the ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, is focused on developing epigenetics-based cancer treatments. The company is headquartered in Houston, Texas.

52W High

$55.05

52W Low

$4.61

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.50

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

1.52

EV/Revenue (<3 favorable)

0.14

P/S (TTM) (<3 favorable)

18.12

P/B (<3 favorable)

67.97

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

0.47%

Institutions (25–75% balanced)

2.51%

Shares Outstanding

509,640

Float

33,930

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

-15,836,828

EPS (TTM)

-23.70

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-6.60%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-1.00

Momentum

Value

N/A

Trend

—

Signal Cross

No cross

As of

—